{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P17813",
      "entity_text" : "end",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "interpro:IPR003310",
      "entity_text" : "mug",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The ENG subdermal contraceptive implant is a device consisting of 68 mg of ENG as the active ingredient with an average release rate of 60-70 mug / day in weeks 5-6, decreasing to ~ 35-45 mug / day by the end of the first year, 30-40 mug / day by year 2, and then to 25-30 mug / day at the end of the third year.",
  "reading_complete" : "2020-08-04T21:05:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T21:03:29Z",
  "trigger" : "decreasing",
  "evidence" : [ "decreasing to ~35-45 mug/day by the end of the first year, 30-40 mug/day by year 2, and then to 25-30 mug/day at the end" ],
  "pmc_id" : "5088635",
  "score" : 0
}